Drug Shortage Report for 0.9% SODIUM CHLORIDE INJECTION, USP
Report ID | 171038 |
Drug Identification Number | 00060208 |
Brand name | 0.9% SODIUM CHLORIDE INJECTION, USP |
Common or Proper name | 0.9% SODIUM CHLORIDE INJECTION, USP |
Company Name | BAXTER CORPORATION |
Market Status | MARKETED |
Active Ingredient(s) | SODIUM CHLORIDE |
Strength(s) | 900MG |
Dosage form(s) | SOLUTION |
Route of administration | INTRAVENOUS INTRAVENOUS |
Packaging size | 250mL (JB0049) |
ATC code | B05XA |
ATC description | I.V. SOLUTION ADDITIVES |
Reason for shortage | Disruption of the manufacture of the drug. |
Anticipated start date | 2022-10-04 |
Actual start date | 2022-10-04 |
Estimated end date | 2022-11-30 |
Actual end date | 2022-11-30 |
Shortage status | Resolved |
Updated date | 2022-12-01 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 7125 MISSISSAUGA ROAD MISSISSAUGA, ONTARIO CANADA L5N 0C2 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v8 | 2022-12-01 | English | Compare |
v7 | 2022-11-29 | French | Compare |
v6 | 2022-11-29 | English | Compare |
v5 | 2022-11-15 | French | Compare |
v4 | 2022-11-15 | English | Compare |
v3 | 2022-10-05 | English | Compare |
v2 | 2022-10-04 | French | Compare |
v1 | 2022-10-04 | English | Compare |
Showing 1 to 8 of 8